Gilead Sciences
GILD
1,555 hedge funds and large institutions have $66.2B invested in Gilead Sciences in 2019 Q4 according to their latest regulatory filings, with 184 funds opening new positions, 502 increasing their positions, 698 reducing their positions, and 71 closing their positions.
159% more first-time investments, than exits
New positions opened: 184 | Existing positions closed: 71
6% more funds holding
Funds holding: 1,462 → 1,555 (+93)
3% more capital invested
Capital invested by funds: $64.4B → $66.2B (+$1.75B)
0.17% more ownership
Funds ownership: 80.36% → 80.53% (+0.17%)
4% less call options, than puts
Call options by funds: $1.4B | Put options by funds: $1.46B
14% less funds holding in top 10
Funds holding in top 10: 43 → 37 (-6)
28% less repeat investments, than reductions
Existing positions increased: 502 | Existing positions reduced: 698
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$543M |
| 2 |
BlackRock
New York
|
+$421M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$182M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$175M |
| 5 |
Renaissance Technologies
New York
|
+$145M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$768M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$175M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$156M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$146M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$128M |
GILD Hedge Fund Activity: Q4 2019 in Review
1,555 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2019, worth a combined $66.2B — up 2.7% from $64.4B a quarter earlier.
Buyers outnumbered sellers: 184 funds opened new GILD positions and 71 closed out — a net gain of 113 holders — while 502 added to existing stakes and 698 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $543M. The largest seller was Invesco, cutting an estimated $768M.
- 1,555 institutional investors held Gilead Sciences (GILD) as of Q4 2019, up from 1,462 in Q3 2019.
- Funds reported $66.2B of Gilead Sciences stock for Q4 2019, up 2.7% quarter-over-quarter.
- 184 funds opened new Gilead Sciences positions in Q4 2019 and 71 closed out, a net change of +113 holders.
- The largest Gilead Sciences buyer in Q4 2019 was Capital Research Global Investors, an estimated $543M added.
- The largest Gilead Sciences seller in Q4 2019 was Invesco, an estimated $768M sold.
Based on aggregated 13F filings for Q4 2019.